Celgene partners with Anokion, lifts 2017 guidance

Celgene Corp. (NASDAQ:CELG) and Anokion S.A. (Ecublens, Switzerland) partnered to use the Swiss biotech's immune tolerizing platform to develop therapies for autoimmune diseases. Celgene made an equity

Read the full 276 word article

User Sign In